Viewing Study NCT00969293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-02-02 @ 3:17 AM
Study NCT ID: NCT00969293
Status: TERMINATED
Last Update Posted: 2012-01-10
First Post: 2009-08-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
Sponsor: Fovea Pharmaceuticals SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Edema View
None Central Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Macular Edema View
None Occlusive retinal vascular disease View
None Central Retinal Vein Occlusion View
None CRVO View